| Treatment with β-blockers and reduced disease progression in patients with thick melanoma V De Giorgi, M Grazzini, S Gandini, S Benemei, T Lotti, N Marchionni, ... Archives of internal medicine 171 (8), 779-781, 2011 | 229 | 2011 |
| Propranolol for off-label treatment of patients with melanoma: results from a cohort study V De Giorgi, M Grazzini, S Benemei, N Marchionni, E Botteri, ... JAMA oncology 4 (2), e172908-e172908, 2018 | 223 | 2018 |
| Application of a filtration-and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma V De Giorgi, P Pinzani, F Salvianti, J Panelos, M Paglierani, A Janowska, ... Journal of Investigative Dermatology 130 (10), 2440-2447, 2010 | 216 | 2010 |
| Cutaneous manifestations of breast carcinoma V De Giorgi, M Grazzini, B Alfaioli, I Savarese, SA Corciova, G Guerriero, ... Dermatologic therapy 23 (6), 581-589, 2010 | 165 | 2010 |
| Effect of β-blockers and other antihypertensive drugs on the risk of melanoma recurrence and death V De Giorgi, S Gandini, M Grazzini, S Benemei, N Marchionni, P Geppetti Mayo Clinic Proceedings 88 (11), 1196-1203, 2013 | 93 | 2013 |
| Paraneoplastic vasculitis and paraneoplastic vascular syndromes Buggiani et al. Vascular syndromes. G Buggiani, A Krysenka, M Grazzini, V Vaškş, J Hercogová, T Lotti Dermatologic therapy 23 (6), 2010 | 82 | 2010 |
| Estrogens, estrogen receptors and melanoma V De Giorgi, A Gori, M Grazzini, S Rossari, F Scarfì, S Corciova, A Verdelli, ... Expert review of anticancer therapy 11 (5), 739-747, 2011 | 79 | 2011 |
| Multiparametric analysis of cell-free DNA in melanoma patients F Salvianti, P Pinzani, P Verderio, CM Ciniselli, D Massi, V De Giorgi, ... PLoS One 7 (11), e49843, 2012 | 77 | 2012 |
| Oestrogen receptor beta and melanoma: a comparative study V De Giorgi, A Gori, S Gandini, F Papi, M Grazzini, S Rossari, A Simoni, ... British journal of dermatology 168 (3), 513-519, 2013 | 72 | 2013 |
| The prognostic impact of the anatomical sites in the ‘head and neck melanoma’: scalp versus face and neck V de Giorgi, S Rossari, A Gori, M Grazzini, I Savarese, E Crocetti, ... Melanoma research 22 (5), 402-405, 2012 | 68 | 2012 |
| Photodynamic treatment for viral infections of the skin. R Rossi, N Bruscino, F Ricceri, M Grazzini, M Dindelli, T Lotti Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa …, 2009 | 66 | 2009 |
| Circulating benign nevus cells detected by ISET technique: warning for melanoma molecular diagnosis V De Giorgi, P Pinzani, F Salvianti, M Grazzini, C Orlando, T Lotti, ... Archives of dermatology 146 (10), 1120-1124, 2010 | 62 | 2010 |
| Multiple primary melanoma: the impact of atypical naevi and follow up V De Giorgi, S Rossari, F Papi, A Gori, B Alfaioli, M Grazzini, E Crocetti, ... British Journal of Dermatology 163 (6), 1319-1322, 2010 | 55 | 2010 |
| Tumor-related methylated cell-free DNA and circulating tumor cells in melanoma F Salvianti, C Orlando, D Massi, V De Giorgi, M Grazzini, M Pazzagli, ... Frontiers in molecular biosciences 2, 76, 2016 | 46 | 2016 |
| Dermoscopy, confocal laser microscopy, and hi‐tech evaluation of vascular skin lesions: diagnostic and therapeutic perspectives M Grazzini, I Stanganelli, S Rossari, A Gori, T Oranges, AS Longo, T Lotti, ... Dermatologic Therapy 25 (4), 297-303, 2012 | 41 | 2012 |
| β-Blocker use and reduced disease progression in patients with thick melanoma: 8 years of follow-up V De Giorgi, M Grazzini, S Benemei, N Marchionni, P Geppetti, S Gandini Melanoma Research 27 (3), 268-270, 2017 | 37 | 2017 |
| Influence of sex hormones on melanoma V de Giorgi, A Gori, B Alfaioli, F Papi, M Grazzini, S Rossari, T Lotti, ... Journal of Clinical Oncology 29 (4), e94-e95, 2011 | 37 | 2011 |
| Is skin self-examination for cutaneous melanoma detection still adequate? A retrospective study V De Giorgi, M Grazzini, S Rossari, A Gori, F Papi, F Scarfi, I Savarese, ... Dermatology 225 (1), 31-36, 2012 | 36 | 2012 |
| Synchronous angiosarcoma, melanoma and morphea of the breast skin 14 years after radiotherapy for mammary carcinoma V De GIoRGI, R Santi, M Grazzini, F Papi, A Gori, S RoSSARI, D Massi, ... Acta dermato-venereologica 90 (3), 283-286, 2010 | 35 | 2010 |
| Further characterization of the potent VEGF/PDGF receptor tyrosine kinase inhibitor, AG013736, in preclinical tumor models for its antiangiogenesis and antitumor activity G Wickman, M Hallin, R Dillon, K Amundson, A Acena, M Grazzini, ... Proc Am Assoc Cancer Res 44, A3780, 2003 | 34 | 2003 |
